The Links between ALS and NF-κB

Int J Mol Sci. 2021 Apr 8;22(8):3875. doi: 10.3390/ijms22083875.

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease wherein motor neuron degeneration leads to muscle weakness, progressive paralysis, and death within 3-5 years of diagnosis. Currently, the cause of ALS is unknown but, as with several neurodegenerative diseases, the potential role of neuroinflammation has become an increasingly popular hypothesis in ALS research. Indeed, upregulation of neuroinflammatory factors have been observed in both ALS patients and animal models. One such factor is the inflammatory inducer NF-κB. Besides its connection to inflammation, NF-κB activity can be linked to several genes associated to familial forms of ALS, and many of the environmental risk factors of the disease stimulate NF-κB activation. Collectively, this has led many to hypothesize that NF-κB proteins may play a role in ALS pathogenesis. In this review, we discuss the genetic and environmental connections between NF-κB and ALS, as well as how this pathway may affect different CNS cell types, and finally how this may lead to motor neuron degeneration.

Keywords: ALS; NF-κB; neuroinflammation.

Publication types

  • Review

MeSH terms

  • Alleles
  • Amyotrophic Lateral Sclerosis / etiology*
  • Amyotrophic Lateral Sclerosis / metabolism*
  • Amyotrophic Lateral Sclerosis / pathology
  • Animals
  • Biomarkers
  • Disease Susceptibility*
  • Environment
  • Enzyme Activation
  • Genetic Predisposition to Disease
  • Genetic Variation
  • Humans
  • Microglia / metabolism
  • Microglia / pathology
  • NF-kappa B / metabolism*
  • Neurons / metabolism
  • Neurons / pathology
  • Oligodendroglia / metabolism
  • Oligodendroglia / pathology

Substances

  • Biomarkers
  • NF-kappa B

Grants and funding